---
title: "Lisdexamfetamine Dimesylate Capsule Shortage: Current Availability and Manufacturer Updates"
summary: "Lisdexamfetamine Dimesylate capsules are currently experiencing supply disruptions, with several manufacturers reporting limited availability or active ingredient shortages through early 2026."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Lisdexamfetamine Dimesylate","Capsule"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T14:38:47.000Z
---
### What's in Shortage
**Drug Name:** Lisdexamfetamine Dimesylate Capsule  
**Brand Name:** LISDEXAMFETAMINE DIMESYLATE  
**Dosage Form:** Capsule (10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, 70 mg)  
**Therapeutic Category:** Psychiatry  
**Current Status:** Current Shortage  
**Initial Posting Date:** 07/14/2023  
**Last Updated:** 02/04/2026

### Which Manufacturers Are Affected
Supply status varies significantly by manufacturer and dosage strength:

*   **Alvogen**: All strengths (10 mg - 70 mg) are currently **Available**. (Contact: 844-842-8672 / CustomerService-US@alvogen.com)
*   **Amneal Pharmaceuticals**: All presentations (20 mg - 70 mg) are **Unavailable** due to active ingredient shortages. (Contact: 866-525-7270)
*   **Elite Laboratories, Inc.**: All strengths (10 mg - 70 mg) are under **Limited Availability**. (Contact: 888-852-6657)
*   **Sun Pharmaceutical Industries, Inc.**: All strengths (10 mg - 70 mg) are under **Limited Availability**, with additional supply anticipated in Q1 2026. (Contact: 800-818-4555)
*   **SpecGx LLC**: All strengths (10 mg - 70 mg) are under **Limited Availability** and are being placed on allocation to customers. (Contact: 800-325-8888)
*   **Teva Pharmaceuticals USA, Inc.**: Status varies by strength. Some are available, while others are under limited availability with estimated recovery dates in February or March 2026. (Contact: 800-545-8800)
*   **Lannett Company, Inc.**: Mixed status. Some strengths (50 mg, 60 mg) are available, while others (10 mg, 70 mg) are unavailable or limited. (Contact: 844-834-0530)
*   **Mylan Pharmaceuticals Inc. (Viatris)**: Mixed status. Strengths 10 mg, 30 mg, 50 mg, and 70 mg are available; 20 mg, 40 mg, and 60 mg are unavailable. (Contact: 800-796-9526)

### Why There's a Shortage
Several manufacturers, including Amneal and Mylan, have cited a **shortage of an active ingredient** as the reason for supply disruptions. Other manufacturers have reported limited availability or customer allocation without specifying a primary cause. Recovery for several impacted lines is estimated for the first quarter of 2026.

### What Patients Should Do
If you are affected by this shortage, please consider the following steps:
*   **Consult Your Healthcare Provider**: Discuss your treatment plan and potential alternatives with your doctor. Do not make changes to your medication without medical supervision.
*   **Speak with Your Pharmacist**: Pharmacists may have information on which specific strengths or manufacturers are currently in stock at their location.
*   **Contact Manufacturers**: You may use the contact information provided above to inquire about the availability of specific National Drug Codes (NDCs).

*Disclaimer: This information is for educational purposes only. Patients should always consult with their healthcare provider regarding medical decisions and treatment options.*

### Source
FDA Drug Shortage Database